OpportunityTitle: Validation and Advanced Development of Technologies for the Study of Biological Properties of Single Cells (R33)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: This Funding Opportunity Announcement (FOA) invites applications that propose to accelerate the development of promising technologies for single cell analysis by taking them through the downstream optimization and validation process and establishing them as robust, well-characterized tools ready to transform our understanding of the biological properties of individual cells and the role those properties have in modulating the states of surrounding cells, tissues, and organs. This FOA solicits projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. A current R21 award is not necessary. Projects should reflect the potential of single cell analysis to have a major impact on our understanding of biomedical processes, fulfill a critical unmet need by offering compelling advantages to end-users, and demonstrate the technology can be applied to multiple types of cells. It is expected that applications will have well-defined goal(s) with intermediate quantitative milestones. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued will be considered non-responsive and will not be reviewed.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;